Quantification of 18F-florbetapir PET: comparison of two analysis methods
Purpose 18 F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been shown to have a high test-retest reliability and good correlation between standardized uptake value ratio (SUVR) and amyloid burden at a...
Saved in:
Published in | European journal of nuclear medicine and molecular imaging Vol. 42; no. 5; pp. 725 - 732 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.04.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1619-7070 1619-7089 1619-7089 |
DOI | 10.1007/s00259-015-2988-7 |
Cover
Abstract | Purpose
18
F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been shown to have a high test-retest reliability and good correlation between standardized uptake value ratio (SUVR) and amyloid burden at autopsy. The goal of this study was to determine how well SUVRs computed using the research method could be reproduced using an automatic quantification method, developed for clinical use.
Methods
Two methods for the quantitative analysis of
18
F-florbetapir PET were compared in a diverse clinical population of 604 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and in a group of 74 younger healthy controls (YHC). Cortex to cerebellum SUVRs were calculated using the research method, which is based on SPM, yielding ‘research SUVRs’, and using syngo.PET Amyloid Plaque, yielding ‘sPAP SUVRs’.
Results
Mean cortical SUVRs calculated using the two methods for the 678 subjects were correlated (
r
= 0.99). Linear regression of sPAP SUVRs on research SUVRs was used to convert the research method SUVR threshold for florbetapir positivity of 1.10 to a corresponding threshold of 1.12 for sPAP. Using the corresponding thresholds, categorization of SUVR values were in agreement between research and sPAP SUVRs for 96.3 % of the ADNI images. SUVRs for all YHC were below the corresponding thresholds.
Conclusion
Automatic florbetapir PET quantification using sPAP yielded cortex to cerebellum SUVRs which were correlated and in good agreement with the well-established research method. The research SUVR threshold for florbetapir positivity was reliably converted to a corresponding threshold for sPAP SUVRs. |
---|---|
AbstractList | Purpose
18
F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been shown to have a high test-retest reliability and good correlation between standardized uptake value ratio (SUVR) and amyloid burden at autopsy. The goal of this study was to determine how well SUVRs computed using the research method could be reproduced using an automatic quantification method, developed for clinical use.
Methods
Two methods for the quantitative analysis of
18
F-florbetapir PET were compared in a diverse clinical population of 604 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and in a group of 74 younger healthy controls (YHC). Cortex to cerebellum SUVRs were calculated using the research method, which is based on SPM, yielding ‘research SUVRs’, and using syngo.PET Amyloid Plaque, yielding ‘sPAP SUVRs’.
Results
Mean cortical SUVRs calculated using the two methods for the 678 subjects were correlated (
r
= 0.99). Linear regression of sPAP SUVRs on research SUVRs was used to convert the research method SUVR threshold for florbetapir positivity of 1.10 to a corresponding threshold of 1.12 for sPAP. Using the corresponding thresholds, categorization of SUVR values were in agreement between research and sPAP SUVRs for 96.3 % of the ADNI images. SUVRs for all YHC were below the corresponding thresholds.
Conclusion
Automatic florbetapir PET quantification using sPAP yielded cortex to cerebellum SUVRs which were correlated and in good agreement with the well-established research method. The research SUVR threshold for florbetapir positivity was reliably converted to a corresponding threshold for sPAP SUVRs. (18)F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been shown to have a high test-retest reliability and good correlation between standardized uptake value ratio (SUVR) and amyloid burden at autopsy. The goal of this study was to determine how well SUVRs computed using the research method could be reproduced using an automatic quantification method, developed for clinical use.PURPOSE(18)F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been shown to have a high test-retest reliability and good correlation between standardized uptake value ratio (SUVR) and amyloid burden at autopsy. The goal of this study was to determine how well SUVRs computed using the research method could be reproduced using an automatic quantification method, developed for clinical use.Two methods for the quantitative analysis of (18)F-florbetapir PET were compared in a diverse clinical population of 604 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and in a group of 74 younger healthy controls (YHC). Cortex to cerebellum SUVRs were calculated using the research method, which is based on SPM, yielding 'research SUVRs', and using syngo.PET Amyloid Plaque, yielding 'sPAP SUVRs'.METHODSTwo methods for the quantitative analysis of (18)F-florbetapir PET were compared in a diverse clinical population of 604 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and in a group of 74 younger healthy controls (YHC). Cortex to cerebellum SUVRs were calculated using the research method, which is based on SPM, yielding 'research SUVRs', and using syngo.PET Amyloid Plaque, yielding 'sPAP SUVRs'.Mean cortical SUVRs calculated using the two methods for the 678 subjects were correlated (r = 0.99). Linear regression of sPAP SUVRs on research SUVRs was used to convert the research method SUVR threshold for florbetapir positivity of 1.10 to a corresponding threshold of 1.12 for sPAP. Using the corresponding thresholds, categorization of SUVR values were in agreement between research and sPAP SUVRs for 96.3 % of the ADNI images. SUVRs for all YHC were below the corresponding thresholds.RESULTSMean cortical SUVRs calculated using the two methods for the 678 subjects were correlated (r = 0.99). Linear regression of sPAP SUVRs on research SUVRs was used to convert the research method SUVR threshold for florbetapir positivity of 1.10 to a corresponding threshold of 1.12 for sPAP. Using the corresponding thresholds, categorization of SUVR values were in agreement between research and sPAP SUVRs for 96.3 % of the ADNI images. SUVRs for all YHC were below the corresponding thresholds.Automatic florbetapir PET quantification using sPAP yielded cortex to cerebellum SUVRs which were correlated and in good agreement with the well-established research method. The research SUVR threshold for florbetapir positivity was reliably converted to a corresponding threshold for sPAP SUVRs.CONCLUSIONAutomatic florbetapir PET quantification using sPAP yielded cortex to cerebellum SUVRs which were correlated and in good agreement with the well-established research method. The research SUVR threshold for florbetapir positivity was reliably converted to a corresponding threshold for sPAP SUVRs. (18)F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been shown to have a high test-retest reliability and good correlation between standardized uptake value ratio (SUVR) and amyloid burden at autopsy. The goal of this study was to determine how well SUVRs computed using the research method could be reproduced using an automatic quantification method, developed for clinical use. Two methods for the quantitative analysis of (18)F-florbetapir PET were compared in a diverse clinical population of 604 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and in a group of 74 younger healthy controls (YHC). Cortex to cerebellum SUVRs were calculated using the research method, which is based on SPM, yielding 'research SUVRs', and using syngo.PET Amyloid Plaque, yielding 'sPAP SUVRs'. Mean cortical SUVRs calculated using the two methods for the 678 subjects were correlated (r = 0.99). Linear regression of sPAP SUVRs on research SUVRs was used to convert the research method SUVR threshold for florbetapir positivity of 1.10 to a corresponding threshold of 1.12 for sPAP. Using the corresponding thresholds, categorization of SUVR values were in agreement between research and sPAP SUVRs for 96.3 % of the ADNI images. SUVRs for all YHC were below the corresponding thresholds. Automatic florbetapir PET quantification using sPAP yielded cortex to cerebellum SUVRs which were correlated and in good agreement with the well-established research method. The research SUVR threshold for florbetapir positivity was reliably converted to a corresponding threshold for sPAP SUVRs. |
Author | Devous, Michael D. Declerck, Jerome Hutton, Chloe Pontecorvo, Michael J. Mintun, Mark A. Joshi, Abhinay D. |
Author_xml | – sequence: 1 givenname: Chloe surname: Hutton fullname: Hutton, Chloe email: chloe.hutton@siemens.com organization: Siemens Molecular Imaging – sequence: 2 givenname: Jerome surname: Declerck fullname: Declerck, Jerome organization: Siemens Molecular Imaging – sequence: 3 givenname: Mark A. surname: Mintun fullname: Mintun, Mark A. organization: Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly and Company – sequence: 4 givenname: Michael J. surname: Pontecorvo fullname: Pontecorvo, Michael J. organization: Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly and Company – sequence: 5 givenname: Michael D. surname: Devous fullname: Devous, Michael D. organization: Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly and Company – sequence: 6 givenname: Abhinay D. surname: Joshi fullname: Joshi, Abhinay D. organization: Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly and Company |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25652817$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1PwyAYgImZcR_6A7yYHr2gQEsBb2bZdMkSNZlnQilVlrZUaGP27-3s3MHDTryH53nf8EzBqHa1AeAaozuMELsPCBEqIMIUEsE5ZGdgglMsIENcjI4zQ2MwDWGLEOaEiwswJjSlhGM2Aau3TtWtLaxWrXV15IoI8yUsSucz06rG-uh1sXmItKsa5W0YkPbbRapW5S7YEFWm_XR5uATnhSqDuTq8M_C-XGzmz3D98rSaP66hJpQyqHjKaCwKqgzPDSeM5VwrlMSG6kylLKGYUJUrlhqtCyTiOMNxLBjXGidCx_EM3A57G---OhNaWdmgTVmq2rguSJymvYBJwnv05oB2WWVy2XhbKb-Tf9_vATwA2rsQvCmOCEZyn1gOiWWfWO4Ty73D_jnatr_xWq9sedIkgxn6K_WH8XLrOt9nDCekH5mzjlo |
CitedBy_id | crossref_primary_10_1007_s00259_016_3601_4 crossref_primary_10_1016_j_nicl_2016_05_004 crossref_primary_10_1016_j_nicl_2018_07_013 crossref_primary_10_6009_jjrt_2017_JSRT_73_4_298 crossref_primary_10_1259_bjr_20181020 crossref_primary_10_1007_s40336_017_0257_4 crossref_primary_10_1007_s13139_022_00767_1 crossref_primary_10_1007_s00259_015_3300_6 crossref_primary_10_1371_journal_pone_0177924 crossref_primary_10_3233_JAD_190329 crossref_primary_10_2174_1874471013666200729155717 crossref_primary_10_1016_j_ejmp_2023_102604 crossref_primary_10_1053_j_semnuclmed_2015_03_008 crossref_primary_10_1002_alz_13567 crossref_primary_10_1016_j_jalz_2016_11_007 crossref_primary_10_2147_CIA_S404908 crossref_primary_10_1007_s00259_017_3644_1 crossref_primary_10_3390_app10072628 crossref_primary_10_6009_jjrt_2021_JSRT_77_1_32 crossref_primary_10_1007_s00259_017_3750_0 |
Cites_doi | 10.2967/jnumed.111.090340 10.1126/science.1072994 10.1006/nimg.2001.0978 10.1016/j.neuroimage.2012.12.014 10.1016/S1474-4422(11)70077-1 10.2967/jnumed.112.109009 10.1002/ana.20009 10.1016/S1474-4422(08)70001-2 10.1002/ana.22068 10.1016/S1474-4422(12)70142-4 10.1007/s00259-013-2415-x 10.1001/archneurol.2011.150 10.1001/jama.2010.2008 10.2967/jnumed.109.069088 10.1016/j.media.2011.05.002 10.2967/jnumed.112.115006 10.2967/jnumed.112.114785 10.1007/s00259-011-1745-9 10.2967/jnumed.113.120618 10.1016/j.jalz.2014.07.003 10.1007/s00259-014-2753-3 10.1109/NSSMIC.1993.373602 10.2967/jnumed.110.076315 |
ContentType | Journal Article |
Copyright | Springer-Verlag Berlin Heidelberg 2015 |
Copyright_xml | – notice: Springer-Verlag Berlin Heidelberg 2015 |
CorporateAuthor | for the Alzheimer’s Disease Neuroimaging Initiative Alzheimer’s Disease Neuroimaging Initiative |
CorporateAuthor_xml | – name: for the Alzheimer’s Disease Neuroimaging Initiative – name: Alzheimer’s Disease Neuroimaging Initiative |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s00259-015-2988-7 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1619-7089 |
EndPage | 732 |
ExternalDocumentID | 25652817 10_1007_s00259_015_2988_7 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Canadian Institutes of Health Research – fundername: NIA NIH HHS grantid: U01 AG024904 |
GroupedDBID | --- -5E -5G -BR -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 199 1N0 203 29G 29~ 2JN 2JY 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 40D 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AACDK AAHNG AAIAL AAJBT AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACIWK ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACUHS ACZOJ ADBBV ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AFBBN AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFRAH AFWTZ AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARAPS ARMRJ AXYYD AZFZN B-. B0M BA0 BBNVY BDATZ BENPR BGLVJ BGNMA BHPHI BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EAD EAP EAS EBB EBC EBD EBLON EBO EBS EBX EHN EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPL EPT ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KPH LAS LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P62 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS Q~Q R89 R9I RNI RNS ROL RPX RRX RSV RZK S1Z S26 S27 S28 S37 S3B SAP SCLPG SDH SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TH9 TSG TSK TT1 TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 WOW YLTOR Z45 Z7R Z7U Z7W Z7X Z7Y Z7Z Z81 Z82 Z83 Z87 Z88 Z8M Z8O Z8Q Z8R Z8S Z8T Z8U Z8V Z8W Z8Z Z91 ZMTXR ~8M AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7X8 PUEGO |
ID | FETCH-LOGICAL-c2557-a867539f5ae8de8277d8ca043e5cba6745125ada76eccf0933b133978cc149c33 |
ISSN | 1619-7070 1619-7089 |
IngestDate | Fri Sep 05 02:54:27 EDT 2025 Mon Jul 21 05:51:49 EDT 2025 Sun Jul 06 05:07:29 EDT 2025 Thu Apr 24 23:03:18 EDT 2025 Fri Feb 21 02:43:39 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Amyloid Florbetapir Quantification Alzheimer’s disease PET |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2557-a867539f5ae8de8277d8ca043e5cba6745125ada76eccf0933b133978cc149c33 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 25652817 |
PQID | 1661331248 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1661331248 pubmed_primary_25652817 crossref_primary_10_1007_s00259_015_2988_7 crossref_citationtrail_10_1007_s00259_015_2988_7 springer_journals_10_1007_s00259_015_2988_7 |
PublicationCentury | 2000 |
PublicationDate | 20150400 |
PublicationDateYYYYMMDD | 2015-04-01 |
PublicationDate_xml | – month: 4 year: 2015 text: 20150400 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany |
PublicationTitle | European journal of nuclear medicine and molecular imaging |
PublicationTitleAbbrev | Eur J Nucl Med Mol Imaging |
PublicationTitleAlternate | Eur J Nucl Med Mol Imaging |
PublicationYear | 2015 |
Publisher | Springer Berlin Heidelberg |
Publisher_xml | – name: Springer Berlin Heidelberg |
References | Rowe, Villemagne (CR10) 2011; 52 Thomas, Erlandsson, Modat, Thurfjell, Vandenberghe, Ourselin (CR25) 2011; 38 Fleisher, Chen, Liu, Roontiva, Thiyyagura, Ayutyanont (CR13) 2011; 68 Hardy, Selkoe (CR1) 2002; 297 Clark, Schneider, Bedell, Beach, Bilker, Mintun (CR5) 2011; 305 Booij, Arbizu, Darcourt, Hesse, Nobili, Payoux (CR9) 2013; 40 CR18 Edison, Carter, Rinne, Gelosa, Herholz, Nordberg (CR22) 2013; 70 Joshi, Pontecorvo, Clark, Carpenter, Jennings, Sadowsky (CR15) 2012; 53 Rowe, Ackerman, Browne, Mulligan, Pike, O’Keefe (CR12) 2008; 7 Peyrat, Joshi, Mintun, Declerck (CR16) 2012 Wong, Rosenberg, Zhou, Kumar, Raymont, Ravert (CR19) 2010; 51 Barthel, Gertz, Dresel, Peters, Bartenstein, Buerger (CR4) 2011; 10 Landau, Breault, Joshi, Pontecorvo, Mathis, Jagust (CR6) 2013; 54 Lopresti, Klunk, Mathis, Hoge, Ziolko, Lu (CR11) 2005; 46 Vandenberghe, Van Laere, Ivanoiu, Salmon, Baslin, Triau (CR3) 2010; 68 Lundqvist, Lilja, Thomas, Lötjönen, Villemagne, Rowe (CR24) 2013; 54 Peyrat, Joshi, Mintun, Declerck (CR23) 2012 Roche, Ribes, Bach-Cuadra, Kruger (CR21) 2011; 15 Tzourio-Mazoyer, Landeau, Papathanassiou, Crivello, Etard, Delcroix (CR20) 2002; 15 CR27 CR26 Clark, Pontecorvo, Beach, Bedell, Coleman, Doraiswamy (CR14) 2012; 11 Friston, Ashburner, Kiebel, Nichols, Penny (CR17) 2007 Rowe, Pejoska, Mulligan, Jones, Chan, Svensson (CR7) 2013; 54 Klunk, Engler, Nordberg, Wang, Blomqvist, Holt (CR2) 2004; 55 Johnson, Minoshima, Bohnen, Donohoe, Foster, Herscovitch (CR8) 2013; 54 P Edison (2988_CR22) 2013; 70 AS Fleisher (2988_CR13) 2011; 68 J-M Peyrat (2988_CR16) 2012 2988_CR18 CM Clark (2988_CR14) 2012; 11 N Tzourio-Mazoyer (2988_CR20) 2002; 15 CC Rowe (2988_CR12) 2008; 7 DF Wong (2988_CR19) 2010; 51 R Lundqvist (2988_CR24) 2013; 54 J Hardy (2988_CR1) 2002; 297 BJ Lopresti (2988_CR11) 2005; 46 R Vandenberghe (2988_CR3) 2010; 68 KA Johnson (2988_CR8) 2013; 54 BA Thomas (2988_CR25) 2011; 38 H Barthel (2988_CR4) 2011; 10 CC Rowe (2988_CR7) 2013; 54 J-M Peyrat (2988_CR23) 2012 2988_CR27 2988_CR26 WE Klunk (2988_CR2) 2004; 55 SM Landau (2988_CR6) 2013; 54 (2988_CR17) 2007 A Roche (2988_CR21) 2011; 15 CC Rowe (2988_CR10) 2011; 52 AD Joshi (2988_CR15) 2012; 53 J Booij (2988_CR9) 2013; 40 CM Clark (2988_CR5) 2011; 305 21621449 - Med Image Anal. 2011 Dec;15(6):830-9 22749065 - Lancet Neurol. 2012 Aug;11(8):669-78 14991808 - Ann Neurol. 2004 Mar;55(3):306-19 23575995 - J Nucl Med. 2013 Jun;54(6):880-6 23359661 - J Nucl Med. 2013 Mar;54(3):476-90 21917849 - J Nucl Med. 2011 Nov;52(11):1733-40 21336694 - Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1104-19 20687209 - Ann Neurol. 2010 Sep;68(3):319-29 12130773 - Science. 2002 Jul 19;297(5580):353-6 23619939 - Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1122-5 22331215 - J Nucl Med. 2012 Mar;53(3):378-84 23740104 - J Nucl Med. 2013 Aug;54(8):1472-8 21747008 - Arch Neurol. 2011 Nov;68(11):1404-11 16330558 - J Nucl Med. 2005 Dec;46(12 ):1959-72 25443857 - Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4 23166389 - J Nucl Med. 2013 Jan;54(1):70-7 23261639 - Neuroimage. 2013 Apr 15;70:423-33 11771995 - Neuroimage. 2002 Jan;15(1):273-89 24647577 - Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407 20501908 - J Nucl Med. 2010 Jun;51(6):913-20 18191617 - Lancet Neurol. 2008 Feb;7(2):129-35 21245183 - JAMA. 2011 Jan 19;305(3):275-83 21481640 - Lancet Neurol. 2011 May;10 (5):424-35 |
References_xml | – volume: 53 start-page: 378 issue: 3 year: 2012 end-page: 384 ident: CR15 article-title: Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer’s disease and cognitively normal subjects publication-title: J Nucl Med doi: 10.2967/jnumed.111.090340 – ident: CR18 – volume: 297 start-page: 353 issue: 5580 year: 2002 end-page: 356 ident: CR1 article-title: The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics publication-title: Science doi: 10.1126/science.1072994 – year: 2012 ident: CR16 publication-title: An automatic method for the quantification of uptake with florbetapir imaging – volume: 15 start-page: 273 issue: 1 year: 2002 end-page: 289 ident: CR20 article-title: Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain publication-title: Neuroimage doi: 10.1006/nimg.2001.0978 – volume: 70 start-page: 423 year: 2013 end-page: 433 ident: CR22 article-title: Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.12.014 – volume: 10 start-page: 424 issue: 5 year: 2011 end-page: 435 ident: CR4 article-title: Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(11)70077-1 – volume: 54 start-page: 70 issue: 1 year: 2013 end-page: 77 ident: CR6 article-title: Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods publication-title: J Nucl Med doi: 10.2967/jnumed.112.109009 – volume: 52 start-page: 1733 issue: 11 year: 2011 end-page: 1740 ident: CR10 article-title: Brain amyloid imaging publication-title: J Nucl Med – volume: 55 start-page: 306 issue: 3 year: 2004 end-page: 319 ident: CR2 article-title: Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B publication-title: Ann Neurol doi: 10.1002/ana.20009 – volume: 7 start-page: 129 issue: 2 year: 2008 end-page: 135 ident: CR12 article-title: Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism publication-title: Lancet Neurol doi: 10.1016/S1474-4422(08)70001-2 – year: 2012 ident: CR23 publication-title: Influence of reconstruction methods and parameters in quantification of uptake with florbetapir imaging – ident: CR27 – volume: 68 start-page: 319 issue: 3 year: 2010 end-page: 329 ident: CR3 article-title: 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial publication-title: Ann Neurol doi: 10.1002/ana.22068 – volume: 11 start-page: 669 issue: 8 year: 2012 end-page: 678 ident: CR14 article-title: Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70142-4 – volume: 46 start-page: 1959 issue: 12 year: 2005 end-page: 1972 ident: CR11 article-title: Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis publication-title: J Nucl Med – year: 2007 ident: CR17 publication-title: Statistical parametric mapping: the analysis of functional brain images – volume: 40 start-page: 1122 issue: 7 year: 2013 end-page: 1125 ident: CR9 article-title: Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-013-2415-x – volume: 68 start-page: 1404 issue: 11 year: 2011 end-page: 1411 ident: CR13 article-title: Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease publication-title: Arch Neurol doi: 10.1001/archneurol.2011.150 – volume: 305 start-page: 275 issue: 3 year: 2011 end-page: 283 ident: CR5 article-title: Use of florbetapir-PET for imaging beta-amyloid pathology publication-title: JAMA doi: 10.1001/jama.2010.2008 – volume: 51 start-page: 913 issue: 6 year: 2010 end-page: 920 ident: CR19 article-title: In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18) publication-title: J Nucl Med doi: 10.2967/jnumed.109.069088 – volume: 15 start-page: 830 issue: 6 year: 2011 end-page: 839 ident: CR21 article-title: On the convergence of EM-like algorithms for image segmentation using Markov random fields publication-title: Med Image Anal doi: 10.1016/j.media.2011.05.002 – volume: 54 start-page: 1472 issue: 8 year: 2013 end-page: 1478 ident: CR24 article-title: Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data publication-title: J Nucl Med doi: 10.2967/jnumed.112.115006 – ident: CR26 – volume: 54 start-page: 880 issue: 6 year: 2013 end-page: 886 ident: CR7 article-title: Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia publication-title: J Nucl Med doi: 10.2967/jnumed.112.114785 – volume: 38 start-page: 1104 issue: 6 year: 2011 end-page: 1119 ident: CR25 article-title: The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-011-1745-9 – volume: 54 start-page: 476 issue: 3 year: 2013 end-page: 490 ident: CR8 article-title: Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association publication-title: J Nucl Med doi: 10.2967/jnumed.113.120618 – volume: 68 start-page: 1404 issue: 11 year: 2011 ident: 2988_CR13 publication-title: Arch Neurol doi: 10.1001/archneurol.2011.150 – ident: 2988_CR27 doi: 10.1016/j.jalz.2014.07.003 – volume: 46 start-page: 1959 issue: 12 year: 2005 ident: 2988_CR11 publication-title: J Nucl Med – volume-title: Influence of reconstruction methods and parameters in quantification of uptake with florbetapir imaging year: 2012 ident: 2988_CR23 – volume: 305 start-page: 275 issue: 3 year: 2011 ident: 2988_CR5 publication-title: JAMA doi: 10.1001/jama.2010.2008 – volume: 70 start-page: 423 year: 2013 ident: 2988_CR22 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.12.014 – volume: 54 start-page: 70 issue: 1 year: 2013 ident: 2988_CR6 publication-title: J Nucl Med doi: 10.2967/jnumed.112.109009 – volume: 54 start-page: 1472 issue: 8 year: 2013 ident: 2988_CR24 publication-title: J Nucl Med doi: 10.2967/jnumed.112.115006 – volume: 11 start-page: 669 issue: 8 year: 2012 ident: 2988_CR14 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70142-4 – ident: 2988_CR26 doi: 10.1007/s00259-014-2753-3 – volume-title: Statistical parametric mapping: the analysis of functional brain images year: 2007 ident: 2988_CR17 – volume: 68 start-page: 319 issue: 3 year: 2010 ident: 2988_CR3 publication-title: Ann Neurol doi: 10.1002/ana.22068 – volume: 51 start-page: 913 issue: 6 year: 2010 ident: 2988_CR19 publication-title: J Nucl Med doi: 10.2967/jnumed.109.069088 – volume: 55 start-page: 306 issue: 3 year: 2004 ident: 2988_CR2 publication-title: Ann Neurol doi: 10.1002/ana.20009 – volume: 53 start-page: 378 issue: 3 year: 2012 ident: 2988_CR15 publication-title: J Nucl Med doi: 10.2967/jnumed.111.090340 – volume-title: An automatic method for the quantification of uptake with florbetapir imaging year: 2012 ident: 2988_CR16 – volume: 54 start-page: 880 issue: 6 year: 2013 ident: 2988_CR7 publication-title: J Nucl Med doi: 10.2967/jnumed.112.114785 – volume: 7 start-page: 129 issue: 2 year: 2008 ident: 2988_CR12 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(08)70001-2 – ident: 2988_CR18 doi: 10.1109/NSSMIC.1993.373602 – volume: 15 start-page: 273 issue: 1 year: 2002 ident: 2988_CR20 publication-title: Neuroimage doi: 10.1006/nimg.2001.0978 – volume: 40 start-page: 1122 issue: 7 year: 2013 ident: 2988_CR9 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-013-2415-x – volume: 38 start-page: 1104 issue: 6 year: 2011 ident: 2988_CR25 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-011-1745-9 – volume: 10 start-page: 424 issue: 5 year: 2011 ident: 2988_CR4 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(11)70077-1 – volume: 297 start-page: 353 issue: 5580 year: 2002 ident: 2988_CR1 publication-title: Science doi: 10.1126/science.1072994 – volume: 54 start-page: 476 issue: 3 year: 2013 ident: 2988_CR8 publication-title: J Nucl Med doi: 10.2967/jnumed.113.120618 – volume: 52 start-page: 1733 issue: 11 year: 2011 ident: 2988_CR10 publication-title: J Nucl Med doi: 10.2967/jnumed.110.076315 – volume: 15 start-page: 830 issue: 6 year: 2011 ident: 2988_CR21 publication-title: Med Image Anal doi: 10.1016/j.media.2011.05.002 – reference: 16330558 - J Nucl Med. 2005 Dec;46(12 ):1959-72 – reference: 23359661 - J Nucl Med. 2013 Mar;54(3):476-90 – reference: 11771995 - Neuroimage. 2002 Jan;15(1):273-89 – reference: 22331215 - J Nucl Med. 2012 Mar;53(3):378-84 – reference: 23166389 - J Nucl Med. 2013 Jan;54(1):70-7 – reference: 20687209 - Ann Neurol. 2010 Sep;68(3):319-29 – reference: 14991808 - Ann Neurol. 2004 Mar;55(3):306-19 – reference: 12130773 - Science. 2002 Jul 19;297(5580):353-6 – reference: 22749065 - Lancet Neurol. 2012 Aug;11(8):669-78 – reference: 23740104 - J Nucl Med. 2013 Aug;54(8):1472-8 – reference: 23619939 - Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1122-5 – reference: 23575995 - J Nucl Med. 2013 Jun;54(6):880-6 – reference: 25443857 - Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4 – reference: 21245183 - JAMA. 2011 Jan 19;305(3):275-83 – reference: 21481640 - Lancet Neurol. 2011 May;10 (5):424-35 – reference: 21917849 - J Nucl Med. 2011 Nov;52(11):1733-40 – reference: 21747008 - Arch Neurol. 2011 Nov;68(11):1404-11 – reference: 21336694 - Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1104-19 – reference: 18191617 - Lancet Neurol. 2008 Feb;7(2):129-35 – reference: 20501908 - J Nucl Med. 2010 Jun;51(6):913-20 – reference: 21621449 - Med Image Anal. 2011 Dec;15(6):830-9 – reference: 23261639 - Neuroimage. 2013 Apr 15;70:423-33 – reference: 24647577 - Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407 |
SSID | ssj0018289 |
Score | 2.1077766 |
Snippet | Purpose
18
F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has... (18)F-Florbetapir positron emission tomography (PET) can be used to image amyloid burden in the human brain. A previously developed research method has been... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 725 |
SubjectTerms | Adolescent Adult Aged Algorithms Alzheimer Disease - diagnostic imaging Aniline Compounds Brain - diagnostic imaging Cardiology Case-Control Studies Data Interpretation, Statistical Ethylene Glycols Female Humans Imaging Male Medicine Medicine & Public Health Middle Aged Nuclear Medicine Oncology Original Article Orthopedics Positron-Emission Tomography - methods Radiology Radiopharmaceuticals |
Title | Quantification of 18F-florbetapir PET: comparison of two analysis methods |
URI | https://link.springer.com/article/10.1007/s00259-015-2988-7 https://www.ncbi.nlm.nih.gov/pubmed/25652817 https://www.proquest.com/docview/1661331248 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZpC2MvY_dll-LBnmZUfJMl722XZF1ps2w4kDcjyzIUWrskzgb79TuyJNtZ2tHtRRhjS-acT8fn6NwQekN5HhNBSixYGWDQ_3PMpSdxxIMiVOGMfq7OIc9m8fEiOlmS5Wi0GWaXNPmR-HVtXsn_cBXuAV9Vluw_cLabFG7ANfAXRuAwjLfi8bcN17E-nd7nsykuwQTPZcOvzlfufJIqm18Muw26zc_a5bYYiW4hvb7xhN5oq5Wqe8xXnS--dTpc2t667vll2-2oB0nTWHf-Rd1h55OESVZaAJ_IrlBCm5II_77KJg_1B6xzVTwLDOQf9SDG37iyzFmFTwYhLlq8grmGqaebBh3Ja-4ZmRwFA-yRgYClOk16R_DrWA_VY4uo-C-CgwTAQvu_nPXsz75m08XpaZZOlukeOggoVd79gw-T2fx7535SZqiy1O2nWXe411af3V5iW6HZsVJ2POyt4pLeR_eMxeG81_B5gEayeojunBk-PkJftlHk1KXzB4ocQNE7p8eQegQw5FgMOQZDj9FiOkk_HmPTYAMLsCQp5gzMxTApCZeskAxoUTDBvSiUROQ8phFog4QXnMaw0Ut19pX7ISiwTAgwrEUYPkH7VV3JZ8iJS0mSUhBOaRnlBWeh9GIv4YTShIFaPUaepVImTPV51QTlIuvqZreEzYCwmSJsRsfobffKlS698reHX1vSZyAgldeLV7LerDMfNFAQOUHExuip5kk3HXwYCZgPb7uWSZnZWuub13p-i7VeoLv9BniJ9pvVRr4C9bXJD9EeXVIY2fTzoQHeb8y8mcQ |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+18F-florbetapir+PET%3A+comparison+of+two+analysis+methods&rft.jtitle=European+journal+of+nuclear+medicine+and+molecular+imaging&rft.au=Hutton%2C+Chloe&rft.au=Declerck%2C+Jerome&rft.au=Mintun%2C+Mark+A&rft.au=Pontecorvo%2C+Michael+J&rft.date=2015-04-01&rft.issn=1619-7089&rft.eissn=1619-7089&rft.volume=42&rft.issue=5&rft.spage=725&rft_id=info:doi/10.1007%2Fs00259-015-2988-7&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1619-7070&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1619-7070&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1619-7070&client=summon |